Drug Database
Back to search

Switzerland· 69828001

Ospolot 20 mg/ml, Suspension zum Einnehmen

A sultiame product containing sultiamum, registered in Switzerland by Desitin Pharma GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC N03AX03

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedOspolot 20 mg/ml, Suspension zum Einn…ATCN03AX03REGISTER NO.69828001PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sultiamumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sultiame is registered in 12 of 19 countries.

Countries holding a registration under ATC N03AX03 (sultiame), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 6 of them publish a price we can compare per daily dose
Search sultiame products by name

Sultiame · ATC N03AX03

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sultiame costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • Switzerland: $4.91 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sultiame · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$4.91
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
sultiamum
Manufacturer
Desitin Pharma GmbH
Country
Switzerland (CH)
ATC code
N03AX03
ATC class
Sultiame
Defined daily dose
0.4 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680698280019
    Fl 250 ml
    CHF 121.4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

12 interactions on record for sultiame.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sultiame against other medicinesHow interaction checks work

Sultiame · interactions on record

12 records

12 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Sultiame in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sultiame products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Ospolot, Sultiam Neuraxpharm
  • Belgium · Ospolot
  • Czechia · Ospolot
  • Germany · Ospolot, Sultiam Neuraxpharm
  • Denmark · Ospolot, Ospolot-Tab
  • Estonia · Ospolot
  • Spain · Ospolot
  • Finland · Ospolot
  • United Kingdom (Northern Ireland) · Ospolot
  • Hungary · Ospolot
  • Ireland · Ospolot
  • Italy · Ospolot
  • Luxembourg · Ospolot
  • Netherlands · Ospolot
  • Norway · Ospolot
  • Poland · Sultiame Desitin
  • Portugal · Ospolot
  • Romania · Ospolot
  • Sweden · Ospolot
  • Slovakia · Ospolot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2afcbeed-0d53-4cf1-8a70-9e124c65b325
GET /v1/drugs/2afcbeed-0d53-4cf1-8a70-9e124c65b325?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "sultiamum 20 mg",
  "valid_from": "2026-02-01",
  "limitations": "[{\"description\":\"SeLECTS-Epilepsie bei Kleinkindern, Kindern und Jugendlichen, die 12 kg oder mehr wiegen (ab einem Alter von 3 Jahren), wenn die Tabletten nicht geschluckt werden können oder keine exakte Dosierung mit den Tabletten erfolgen kann.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2026-02-01\"}]",
  "galenic_form": "Susp 20 mg/ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2026-02-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about sultiame.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console